Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The lancet 399 (10325), 629-655, 2022 | 7537 | 2022 |
Artemisinin Resistance in Plasmodium falciparum Malaria AM Dondorp, F Nosten, P Yi, D Das, AP Phyo, J Tarning, KM Lwin, F Ariey, ... New England journal of medicine 361 (5), 455-467, 2009 | 4082 | 2009 |
Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones ofStaphylococcus aureus MC Enright, NPJ Day, CE Davies, SJ Peacock, BG Spratt Journal of clinical microbiology 38 (3), 1008-1015, 2000 | 3806 | 2000 |
Spread of artemisinin resistance in Plasmodium falciparum malaria EA Ashley, M Dhorda, RM Fairhurst, C Amaratunga, P Lim, S Suon, ... New England Journal of Medicine 371 (5), 411-423, 2014 | 2317 | 2014 |
South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group: Artesunate versus quinine for treatment of severe falciparum malaria: a randomized trial A Dondorp Lancet 366, 717-725, 2005 | 1285* | 2005 |
Evolution of MRSA during hospital transmission and intercontinental spread SR Harris, EJ Feil, MTG Holden, MA Quail, EK Nickerson, N Chantratita, ... Science 327 (5964), 469-474, 2010 | 1275 | 2010 |
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance MTG Holden, EJ Feil, JA Lindsay, SJ Peacock, NPJ Day, MC Enright, ... Proceedings of the National Academy of Sciences 101 (26), 9786-9791, 2004 | 1220 | 2004 |
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial AM Dondorp, CI Fanello, ICE Hendriksen, E Gomes, A Seni, ... The Lancet 376 (9753), 1647-1657, 2010 | 1130 | 2010 |
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study AP Phyo, S Nkhoma, K Stepniewska, EA Ashley, S Nair, R McGready, ... The Lancet 379 (9830), 1960-1966, 2012 | 1079 | 2012 |
Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis D Limmathurotsakul, N Golding, DAB Dance, JP Messina, DM Pigott, ... Nature microbiology 1 (1), 1-5, 2016 | 964 | 2016 |
Artemisinin resistance: current status and scenarios for containment AM Dondorp, S Yeung, L White, C Nguon, NPJ Day, D Socheat, ... Nature Reviews Microbiology 8 (4), 272-280, 2010 | 835 | 2010 |
Neurological manifestations of dengue infection T Solomon, NM Dung, DW Vaughn, R Kneen, B Raengsakulrach, ... The Lancet 355 (9209), 1053-1059, 2000 | 816 | 2000 |
How Clonal Is Staphylococcus aureus? EJ Feil, JE Cooper, H Grundmann, DA Robinson, MC Enright, T Berendt, ... Journal of bacteriology 185 (11), 3307-3316, 2003 | 807 | 2003 |
Virulent Combinations of Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus SJ Peacock, CE Moore, A Justice, M Kantzanou, L Story, K Mackie, ... Infection and immunity 70 (9), 4987-4996, 2002 | 804 | 2002 |
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei WJ Wiersinga, T Van der Poll, NJ White, NP Day, SJ Peacock Nature Reviews Microbiology 4 (4), 272-282, 2006 | 729 | 2006 |
Artesunate combinations for treatment of malaria: meta-analysis International Artemisinin Study Group The Lancet 363 (9402), 9-17, 2004 | 728 | 2004 |
Genetic architecture of artemisinin-resistant Plasmodium falciparum O Miotto, R Amato, EA Ashley, B MacInnis, J Almagro-Garcia, ... Nature genetics 47 (3), 226-234, 2015 | 650 | 2015 |
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences EJ Feil, EC Holmes, DE Bessen, MS Chan, NPJ Day, MC Enright, ... Proceedings of the National Academy of Sciences 98 (1), 182-187, 2001 | 627 | 2001 |
The prognostic and pathophysiologic role of pro-and antiinflammatory cytokines in severe malaria NPJ Day, TT Hien, T Schollaardt, PP Loc, LV Chuong, TT Hong Chau, ... The Journal of infectious diseases 180 (4), 1288-1297, 1999 | 565 | 1999 |
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis CC Khor, SJ Chapman, FO Vannberg, A Dunne, C Murphy, EY Ling, ... Nature genetics 39 (4), 523-528, 2007 | 561 | 2007 |